Flutamide: all 33 studies that test it

Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.

• Pembrolizumab in Combination with Flutamide Treatment for Recurrence / Metastasis HNSCCNot yet recruitingNCT06694350Phase 2
• Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen SuppressionCompletedNCT03507608Early Phase 1Results posted
• Study on Enzalutamide and Flutamide in Patients With Castration Resistant Prostate CancerCompletedNCT02918968Phase 4Results posted
• Androgen Excess as a Cause for Adipogenic Dysfunction in PCOS WomenCompletedNCT01889199Phase 2Results posted
• Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate CancerCompletedNCT00936390Phase 3Results posted
• Effects of Flutamide on Insulin and Glucose Metabolism in Women With Polycystic Ovary SyndromeTerminatedNCT00729560Not applicableResults posted
• Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian CancerCompletedNCT00699907Phase 2Results posted
• Effectiveness of Flutamide in Treating Women With Premenstrual Dysphoric DisorderCompletedNCT00611923Phase 4Results posted
• Prostate Radiation Therapy or Short-Term Androgen Deprivation Therapy and Pelvic Lymph Node Radiation Therapy With or Without Prostate Radiation Therapy in Treating Patients With a Rising Prostate Specific Antigen (PSA) After Surgery for Prostate CancerActive, not recruitingNCT00567580Phase 3Results posted
• Metabolic Syndrome in PCOS: Precursors and InterventionsCompletedNCT00442689Not applicableResults posted
• External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate CancerTerminatedNCT00388804Phase 3Results posted
• Effects of IAS in Men With Localized Biochemical Relapsed Prostate CancerCompletedNCT00223665Phase 2Results posted
• Hormone Therapy and Radiation Therapy in Treating Patients With Prostate CancerCompletedNCT00005044Phase 3Results posted
• Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for RecurrenceTerminatedNCT00003645Phase 3Results posted
• Radiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00002597Phase 3Results posted
• Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal HyperplasiaCompletedNCT00001521Phase 3Results posted
• Finasteride and Flutamide in Pre-surgical Trial in Prostate Cancer.CompletedNCT06601205Phase 2/3
• Evaluation of Efficacy of Topical Flutamide in the Treatment of Acne VulgarisCompletedNCT05478330Not applicable
• Two Studies for Patients With Unfavorable Intermediate Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a Higher Gene Risk Score, The Guidance TrialActive, not recruitingNCT05050084Phase 3
• Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT TrialActive, not recruitingNCT04513717Phase 3
• Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer PatientsStatus unknownNCT04248621Phase 4
• Effect of High Testosterone on Sleep-associated Slowing of Follicular Luteinizing Hormone (LH) Frequency in Polycystic Ovary SyndromeStatus unknownNCT00930228Phase 1
• Intermittent Hormonal Therapy With Leuprorelin and Flutamide in the Treatment of Stage D2 or TxNxM1b,cCompletedNCT00817739Phase 2
• Radiation Therapy and Hormone Therapy in Treating Patients With Prostate CancerCompletedNCT00769548Phase 3
• Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate CancerCompletedNCT00116220Phase 3
• Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00104741Phase 3
• Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate CancerCompletedNCT00030654Phase 3
• Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate CancerCompletedNCT00023829Phase 3
• Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the ProstateCompletedNCT00006214Phase 2
• Hormone Therapy in Treating Patients With Rising PSA Levels Following Radiation Therapy for Prostate CancerCompletedNCT00003653Phase 3
• Hormone Therapy in Treating Patients With Prostate CancerCompletedNCT00003323Phase 2
• Flutamide, Suramin, and Hydrocortisone in Treating Patients With Prostate CancerCompletedNCT00002881Phase 3
• Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate CancerCompletedNCT00002855Phase 3

← Flutamide overview